119 related articles for article (PubMed ID: 18650266)
1. Chemotoxicity of doxorubicin and surface expression of P-glycoprotein (MDR1) is regulated by the Pseudomonas aeruginosa toxin Cif.
Ye S; MacEachran DP; Hamilton JW; O'Toole GA; Stanton BA
Am J Physiol Cell Physiol; 2008 Sep; 295(3):C807-18. PubMed ID: 18650266
[TBL] [Abstract][Full Text] [Related]
2. Drug concentration-dependent expression of multidrug resistance-associated protein and P-glycoprotein in the doxorubicin-resistant acute myelogenous leukemia sublines.
Choi CH; Kim HS; Rha HS; Jeong JH; Park YH; Min YD; Kee KH; Lim DY
Mol Cells; 1999 Jun; 9(3):314-9. PubMed ID: 10420992
[TBL] [Abstract][Full Text] [Related]
3. Protein kinase Cα protects against multidrug resistance in human colon cancer cells.
Lee SK; Shehzad A; Jung JC; Sonn JK; Lee JT; Park JW; Lee YS
Mol Cells; 2012 Jul; 34(1):61-9. PubMed ID: 22639047
[TBL] [Abstract][Full Text] [Related]
4. Effects of carvedilol on MDR1-mediated multidrug resistance: comparison with verapamil.
Kakumoto M; Sakaeda T; Takara K; Nakamura T; Kita T; Yagami T; Kobayashi H; Okamura N; Okumura K
Cancer Sci; 2003 Jan; 94(1):81-6. PubMed ID: 12708479
[TBL] [Abstract][Full Text] [Related]
5. Anthracyclines, proteasome activity and multi-drug-resistance.
Fekete MR; McBride WH; Pajonk F
BMC Cancer; 2005 Sep; 5():114. PubMed ID: 16159384
[TBL] [Abstract][Full Text] [Related]
6. Novel pyxinol amide derivatives bearing an aliphatic heterocycle as P-glycoprotein modulators for overcoming multidrug resistance.
Yu L; Ren R; Li S; Zhang C; Chen C; Lv H; Zou Z; Pei X; Song Z; Zhang P; Wang H; Yang G
Eur J Med Chem; 2024 Jun; 272():116466. PubMed ID: 38704938
[TBL] [Abstract][Full Text] [Related]
7. Crystal structure of the cystic fibrosis transmembrane conductance regulator inhibitory factor Cif reveals novel active-site features of an epoxide hydrolase virulence factor.
Bahl CD; Morisseau C; Bomberger JM; Stanton BA; Hammock BD; O'Toole GA; Madden DR
J Bacteriol; 2010 Apr; 192(7):1785-95. PubMed ID: 20118260
[TBL] [Abstract][Full Text] [Related]
8. Small molecules that dramatically alter multidrug resistance phenotype by modulating the substrate specificity of P-glycoprotein.
Kondratov RV; Komarov PG; Becker Y; Ewenson A; Gudkov AV
Proc Natl Acad Sci U S A; 2001 Nov; 98(24):14078-83. PubMed ID: 11707575
[TBL] [Abstract][Full Text] [Related]
9. Pim-1 kinase protects P-glycoprotein from degradation and enables its glycosylation and cell surface expression.
Xie Y; Burcu M; Linn DE; Qiu Y; Baer MR
Mol Pharmacol; 2010 Aug; 78(2):310-8. PubMed ID: 20460432
[TBL] [Abstract][Full Text] [Related]
10. Endoplasmic reticulum-targeting doxorubicin: a new tool effective against doxorubicin-resistant osteosarcoma.
Buondonno I; Gazzano E; Tavanti E; Chegaev K; Kopecka J; Fanelli M; Rolando B; Fruttero R; Gasco A; Hattinger C; Serra M; Riganti C
Cell Mol Life Sci; 2019 Feb; 76(3):609-625. PubMed ID: 30430199
[TBL] [Abstract][Full Text] [Related]
11. Tracing the substrate translocation mechanism in P-glycoprotein.
Gewering T; Waghray D; Parey K; Jung H; Tran NNB; Zapata J; Zhao P; Chen H; Januliene D; Hummer G; Urbatsch I; Moeller A; Zhang Q
Elife; 2024 Jan; 12():. PubMed ID: 38259172
[TBL] [Abstract][Full Text] [Related]
12. Cytoprotective effects of acidosis via heat shock protein HSP27 against the anticancer drug doxorubicin.
Singh AK; Manns MP; Seidler U
Cell Mol Life Sci; 2011 Mar; 68(6):1041-51. PubMed ID: 20730553
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of multidrug recognition by MDR1/ABCB1.
Kimura Y; Morita SY; Matsuo M; Ueda K
Cancer Sci; 2007 Sep; 98(9):1303-10. PubMed ID: 17608770
[TBL] [Abstract][Full Text] [Related]
14. Significance of MDR1 and multiple drug resistance in refractory human epileptic brain.
Marchi N; Hallene KL; Kight KM; Cucullo L; Moddel G; Bingaman W; Dini G; Vezzani A; Janigro D
BMC Med; 2004 Oct; 2():37. PubMed ID: 15473912
[TBL] [Abstract][Full Text] [Related]
15. P-Glycoprotein/MDR1 regulates pokemon gene transcription through p53 expression in human breast cancer cells.
He S; Liu F; Xie Z; Zu X; Xu W; Jiang Y
Int J Mol Sci; 2010 Aug; 11(9):3309-051. PubMed ID: 20957096
[TBL] [Abstract][Full Text] [Related]
16. Drug-Induced Conformational Dynamics of P-Glycoprotein Underlies the Transport of Camptothecin Analogs.
Mensah GAK; Schaefer KG; Bartlett MG; Roberts AG; King GM
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003248
[TBL] [Abstract][Full Text] [Related]
17. Temozolomide down-regulates P-glycoprotein in human blood-brain barrier cells by disrupting Wnt3 signaling.
Riganti C; Salaroglio IC; Pinzòn-Daza ML; Caldera V; Campia I; Kopecka J; Mellai M; Annovazzi L; Couraud PO; Bosia A; Ghigo D; Schiffer D
Cell Mol Life Sci; 2014 Feb; 71(3):499-516. PubMed ID: 23771630
[TBL] [Abstract][Full Text] [Related]
18. Nanocarriers enhance Doxorubicin uptake in drug-resistant ovarian cancer cells.
Arora HC; Jensen MP; Yuan Y; Wu A; Vogt S; Paunesku T; Woloschak GE
Cancer Res; 2012 Feb; 72(3):769-78. PubMed ID: 22158944
[TBL] [Abstract][Full Text] [Related]
19. Probing cholesterol binding and translocation in P-glycoprotein.
Thangapandian S; Kapoor K; Tajkhorshid E
Biochim Biophys Acta Biomembr; 2020 Jan; 1862(1):183090. PubMed ID: 31676371
[TBL] [Abstract][Full Text] [Related]
20. Selection of pancreatic cancer cell-binding landscape phages and their use in development of anticancer nanomedicines.
Bedi D; Gillespie JW; Petrenko VA
Protein Eng Des Sel; 2014 Jul; 27(7):235-43. PubMed ID: 24899628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
